Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Pharma Bio Services (PBSV) Stock Price & Analysis

PBSV Stock Chart & Stats

$0.52$0.00(0.00%)
At close: 4:00 PM EDT
$0.4$0.519 Aug1 Sep15 Sep28 Sep13 Oct27 Oct
Day’s Range
$0.52 - $0.52
52-Week Range
$0.32 - $0.65
Previous Close
$0.52
Volume
2,510
Average Volume (3M)
4,145
Market Cap
$11.91M
Enterprise Value
$1.10M
Total Cash (Recent Filing)
$8.58M
Total Debt (Recent Filing)
$0
Price to Earnings (P/E)
―
Beta
0.39
Next Earnings
Feb 01, 2027 (Est.)
EPS Estimate
0.03
Last Dividend Ex-Date
Feb 27, 2026
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

Extremely low leverage reduces financial pressure and limits interest-related obligations, giving the company greater flexibility to manage periods of weak profitability. This balance-sheet strength also preserves capacity to fund operations or pursue opportunities without relying heavily on additional borrowing.

Sizable Equity Base

A substantial equity base provides a meaningful cushion against operating volatility and supports financial resilience while the company works through recent losses. It also gives management more room to allocate resources toward operations without the constraints associated with a highly leveraged capital structure.

Strong TTM Revenue Scale

The sharp increase in trailing-twelve-month revenue demonstrates that the business has expanded materially from its earlier revenue base. Although this growth has not yet translated into profit, a larger revenue platform can support improved operating leverage if margins and execution stabilize.

Bears Say

Sustained Operating Losses

Persistent operating and net losses show that recent revenue expansion is not currently producing earnings. If negative margins continue, the company may struggle to convert scale into durable profitability, limiting internally generated capital and weakening the quality of its growth.

Negative Operating And Free Cash Flow

Sustained negative operating and free cash flow indicates that operations are consuming cash rather than funding themselves. Continued cash burn can erode the company’s financial resources over time and increase reliance on existing balance-sheet resources to maintain operations.

Negative Returns On Equity

Negative return on equity indicates that the company’s sizable capital base is not currently generating positive returns for shareholders. This points to weak capital efficiency and reinforces the concern that balance-sheet strength has not yet translated into sustainable operating performance.

Pharma Bio Services News

PBSV FAQ

What was Pharma Bio Services’s price range in the past 12 months?
Pharma Bio Services lowest stock price was $0.32 and its highest was $0.65 in the past 12 months.
What is Pharma Bio Services’s market cap?
Pharma Bio Services’s market cap is $11.91M.
When is Pharma Bio Services’s upcoming earnings report date?
Pharma Bio Services’s next earnings report is estimated for Feb 01, 2027 (not yet confirmed), which is in 91 days.
How were Pharma Bio Services’s earnings last quarter?
Pharma Bio Services released its earnings results on Sep 14, 2026. The company reported $0 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$0.03.
Is Pharma Bio Services overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Pharma Bio Services pay dividends?
Pharma Bio Services pays a Notavailable dividend of $0.075 which represents an annual dividend yield of ―. See more information on Pharma Bio Services dividends here
What is Pharma Bio Services’s EPS estimate?
Pharma Bio Services’s EPS estimate is 0.03.
How many shares outstanding does Pharma Bio Services have?
Pharma Bio Services has 22,901,691 shares outstanding.
What happened to Pharma Bio Services’s price movement after its last earnings report?
Pharma Bio Services reported an EPS of $0 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of Pharma Bio Services?
Currently, no hedge funds are holding shares in PBSV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology